US drug regulator promotes veteran to quell unrest in top ranks
Elevation of Richard Pazdur expected to improve FDA staff morale and smooth relations with the pharmaceutical industry
Related reading
Return of FDA official targeted by Trump allies hits biotech shares
Food and Drug Administration reinstates Vinay Prasad who left agency in July after social media campaign
FDA chief seeks to soothe US biotech fears over drug approval timeline
Commissioner says agency is hiring scientists as industry warns over delays
Resignation of head of US food and drug regulator adds to mounting health…
Lawyer Kyle Diamantas appointed FDA’s acting leader as concerns mount over hantavirus outbreak
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
Europe races to placate pharma as Donald Trump turns up the pressure
Tariff deals with the US have bought time but investment momentum is elsewhere
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments